Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the Nine Months Ended September 30, 2021
October 27, 2021 at 04:26 am EDT
Tibet Rhodiola Pharmaceutical Holding Co. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 1,561.92 million compared to CNY 989.59 million a year ago. Revenue was CNY 1,561.92 million compared to CNY 989.59 million a year ago. Net income was CNY 418.48 million compared to CNY 324.45 million a year ago. Basic earnings per share from continuing operations was CNY 1.69 compared to CNY 1.5 a year ago. Diluted earnings per share from continuing operations was CNY 1.69 compared to CNY 1.5 a year ago.